C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/7105 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2727195
The invention relates to methods for cancer diagnosis, prognosis, and treatment based on the expression or activity levels of RUNX3 and miR- 532-5p. Also disclosed is a method of reducing the inhibition of RUNX3 by miR-532-5p with an agent that interferes with the interaction between RUNX3 and miR-532-5p transcripts.
La présente invention concerne des procédés de diagnostic, pronostic et traitement du cancer basés sur l'expression ou les niveaux d'activité de RUNX3 et de miR-532-5p. Elle concerne également un procédé permettant de réduire l'inhibition de RUNX3 par miR-532-5p à l'aide d'un agent qui interfère avec l'interaction entre des transcriptions de RUNX3 et de miR-532-5p.
Hoon Dave S. B.
Kitago Minoru
John Wayne Cancer Institute
Smart & Biggar
LandOfFree
Use of runx3 and mir-532-5p as cancer markers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of runx3 and mir-532-5p as cancer markers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of runx3 and mir-532-5p as cancer markers and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1409522